Alatrofloxacin

DB09335ApprovedWithdrawnSmall molecule

Alatrofloxacin is a fluoroquinolone antibiotic used to treat a variety of bacterial infections. Alatrofloxacin is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.

Formula / weight: C₂₆H₂₅F₃N₆O₅ · 558.518 g/mol (avg)
First approval: Canada, 1998

Resolves to

Compound

UNII7QVV6I50DTCAS146961-76-4ChEMBLCHEMBL1201197ChEBI135829PubChem3086677

Clinical / RWD

RxNorm141440

Structure

InChIKeyUUZPPAMZDFLUHD-VUJLHGSVSA-NSMILES[H][C@@]12CN(C[C@]1([H])[C@H]2NC(=O)[C@H](C)NC(=O)[C@H](C)N)C1=NC2=C(C=C1F)C(=O)C(=CN2C1=CC=C(F)C=C1F)C(O)=O

What you can answer from here — as of September 19, 2026

558Drug interactionsStructured to mechanism, not free text

1Marketed productAcross 1 country and 1 labeller

Which companies are running trials of Alatrofloxacin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account